norfloxacin has been researched along with lupeol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Kim, H; Lee, DG | 1 |
2 other study(ies) available for norfloxacin and lupeol
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Lupeol-induced nitric oxide elicits apoptosis-like death within Escherichia coli in a DNA fragmentation-independent manner.
Topics: Anti-Bacterial Agents; Apoptosis; Calcium; Cell Division; Cell Membrane; DNA Fragmentation; DNA-Binding Proteins; DNA, Bacterial; Drug Evaluation, Preclinical; Escherichia coli; Escherichia coli Proteins; Lipid Peroxidation; Magnesium; Membrane Lipids; Membrane Potentials; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norfloxacin; Pentacyclic Triterpenes; Rec A Recombinases; SOS Response, Genetics | 2021 |